Skip to main content
Caplight Logo









DigitecPharma

DigitecPharma

Private
La CiotatHealthcare & Life Scienceshttps://digitecpharma.fr/

Last Round

Seed

Feb 17, 2021

Total Funding Raised

$1.45M

Company Overview

DigitecPharma operates in Healthcare & Life Sciences and is based in La Ciotat. Its latest recorded funding round was a Seed round in February 2021.

DigitecPharma is a health technology company that provides a digital patient relationship management platform for pharmacies.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, CRM, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

DigitecPharma Comparables

Compare DigitecPharma with similar companies based on industry and business-model similarity.

DigitecPharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Faks
84%
Lumistry
77%
Equasens Group
74%
Book a demo to see all comparables

For institutional investors. Book with your work email.

DigitecPharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 17, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

DigitecPharma Investors

Notable investors and investment history

DigitecPharma investors
InvestorRounds
Région Sud InvestissementSeed
ExtensSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 2, 2026

    Monthly visitors increased 58% MoM.

  • Nov 10, 2025

    Monthly visitors increased 1563% MoM, reaching 1.6K.

Book a demo to see all signals

For institutional investors. Book with your work email.

DigitecPharma Filings

Explore SEC and related filing metadata, where available.

DigitecPharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about DigitecPharma's valuation, stock price, and market status.

Is DigitecPharma a public or private company?

DigitecPharma is a private company.

What is the current stock price of DigitecPharma?

DigitecPharma is a private company, so its shares have no public market price. Caplight tracks DigitecPharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is DigitecPharma worth (valuation)?

Valuation information for DigitecPharma is not publicly available.

Can I buy DigitecPharma stock?

DigitecPharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was DigitecPharma's last funding round?

DigitecPharma's most recent funding round was Seed on February 17, 2021.

Who are the main investors in DigitecPharma?

Key investors in DigitecPharma include Extens.

Will DigitecPharma IPO soon?

No public IPO plans have been announced for DigitecPharma.

How can I track DigitecPharma secondary market activity?

Caplight tracks bids, offers, and trades in DigitecPharma's shares on secondary markets.

Firmographic Details

HeadquartersLa Ciotat
Employee Range14
Year Founded2007
Last FundingFeb 17, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?